Gill Capital Partners’s NeoGenomics NEO Stock Holding History

Gill Capital Partners’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.56K	Buy	+345	New	+$3.63K	﹤0.01%	539

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Gill Capital Partners's NEO Position: Q1 2026 in Review

Gill Capital Partners opened a new position in NeoGenomics (NEO) in Q1 2026: 345 shares worth $2.56K. The stake represents ﹤0.01% of the portfolio and ranks #539 among its holdings.

253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Gill Capital Partners held 345 shares of NeoGenomics worth $2.56K as of Q1 2026.
NeoGenomics was a new Gill Capital Partners position in Q1 2026.
NeoGenomics made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #539 holding.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.